
Gluconorm-PG-L1 Tablet SR
Marketer
Lupin Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Gluconorm-PG-L1 Tablet SR
Metformin and Glimepiride extended-release tablets are a dual-action medication designed to manage elevated blood glucose. This formulation, used in conjunction with a healthy diet and regular exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin utilization, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food is recommended to minimize gastrointestinal discomfort. For missed doses, administer as soon as recalled; however, if nearing the next scheduled dose, omit the missed dose and resume your regular schedule. Avoid doubling the dose to prevent potential hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Commonly reported adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before initiating this medication. Kidney function assessment will be conducted prior to treatment commencement. Limit alcohol consumption as it may exacerbate side effects.
Primary Ingredients of Gluconorm-PG-L1 Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Gluconorm-PG-L1 Tablet SR
Managing type 2 diabetes
Major Benefits of Gluconorm-PG-L1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gluconorm-PG-L1 Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
Common Side effects of Gluconorm-PG-L1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gluconorm-PG-L1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gluconorm-PG-L1 Tablet SR should be administered with a meal.
How Gluconorm-PG-L1 Tablet SR works:
Gluconorm-PG-L1 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to optimize blood glucose management when single or dual-drug regimens prove inadequate. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gluconorm-PG-L1 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Gluconorm-PG-L1 Tablet SR during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Gluconorm-PG-L1 tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Gluconorm-PG-L1 Tablet SR; dosage modification may be necessary. Severe kidney disease contraindicates the use of Gluconorm-PG-L1 Tablet SR. Physician consultation is recommended. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Gluconorm-PG-L1 SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Gluconorm-PG-L1 SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Gluconorm-PG-L1 Tablet SR :
Should you forget a Gluconorm-PG-L1 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Gluconorm-PG-L1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
